Dr. William Borj Tabayoyong, MD, PhD

Dr. Tabayoyong practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Tabayoyong's NPI, 1124319850, was assigned on April 28, 2011. Dr. Tabayoyong graduated from University of Iowa Roy J. and Lucille A. Carver College of Medicine in 2011. Dr. Tabayoyong holds New York license 299919.

Dr. Tabayoyong's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Tabayoyong's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Tabayoyong is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medicine Urology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabayoyong practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Tabayoyong's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Tabayoyong is licensed in New York.

CMS data shows 224 Medicare services from Dr. Tabayoyong across 5 procedure codes in 2024, for 150 Medicare patients. Medicare paid $12,912 for them.

CMS counts 150 Medicare patients who saw Dr. Tabayoyong in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tabayoyong's median patient age at 71, with 37% women.

In 2024, Dr. Tabayoyong wrote 100 Medicare Part D claims for 50 patients. 91% of them were for generic drugs. CMS names the drug for 42 of them, across 1 drug with 11 or more claims each, at $676 in total drug cost. In 2023, CMS named 109 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Tabayoyong for performance year 2024, reported as part of a group. Dr. Tabayoyong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tabayoyong as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Tabayoyong, published from 2015 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Urinary Bladder Neoplasms, Randomized Controlled Trials as Topic and Administration, Intravesical. Dr. Tabayoyong's most frequent co-authors are Ashish M. Kamat, MD, Robert Abouassaly, MD and Edward E. Cherullo, MD.

CMS Open Payments shows 6 general payments to Dr. Tabayoyong from 3 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $387.

Dr. Tabayoyong graduated from University of Iowa Roy J. and Lucille A. Carver College of Medicine in 2011.